Form D · Other
ALLOTROPE MEDICAL INC.
Houston, TX · CIK 0001702408
Offering snapshot reported Apr 27, 2021 · SEC filing
- Reported sold
- $5.05M Offering amount: $5.57M
- Investors reported
- 90 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,040,313 → $5,045,284
- Reported investors53 → 90
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2021 | Amendment | $5,045,284 | $2,004,971vs Mar 11, 2021 | 90 | SEC filing |
| Mar 11, 2021 | Initial | $3,040,313 | No comparison | 53 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-391950
Source: Form D, filed Apr 27, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Franklin | Director |
| Donald Gonzales | Director |
| Albert Huang | Director, Executive |
| Mira Sahney | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2450 Holcombe Blvd Suite X
Houston, TX, 77098
Houston, TX, 77098